DexCom, Inc. (DXCM) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

All participants are in a listen-only mode. Later, we will conduct a question and answer session. During the question and answer session, if you have a question, please press star followed by the number one on your touchtone phone. As a reminder, the conference is being recorded. I will now turn the call over to Shawn Christensen, Vice President of Finance and Investor Relations. Shawn, you may begin. Welcome to Dexcom's first quarter 2025 earnings call. Our agenda begins with Kevin Sayre, Dexcom's chairman, president, and CEO, who will summarize our recent highlights and ongoing strategic initiatives, followed by a financial review and outlook from Jeremy Sylvain, our chief financial officer. Following our prepared remarks, we will open the call up for your questions. At that time, we ask analysts to limit themselves to one question each so we can provide an opportunity for everyone participating today. Please note that there are also slides available related to our first quarter 2025 performance on the Dexcom Investor Relations website on the events and presentations page. With that, let's review our safe harbor statement. Some of the statements we will make on today's call may constitute forward-looking statements. These statements reflect management's intentions, beliefs, and expectations about future events, strategies, competition, products, operating plans, and performance. All forward-looking statements included on this call are made as of the date hereof, based on information currently available to Dexcom, are subject to various risks and uncertainties, and actual results could differ materially from those anticipated in the forward-looking statements. The factors that could cause actual results to differ materially from those expressed or implied by any of ...